Formycon AG (ETR:FYB)
19.90
+1.46 (7.92%)
Aug 26, 2026, 5:35 PM CET
Formycon AG Revenue
Formycon AG had revenue of 12.88M EUR in the quarter ending June 30, 2026, with 186.35% growth. This brings the company's revenue in the last twelve months to 61.24M, up 18.28% year-over-year. In the year 2025, Formycon AG had annual revenue of 44.48M, down -36.17%.
Revenue (ttm)
61.24M
Revenue Growth
+18.28%
P/S Ratio
5.74
Revenue / Employee
312.46K
Employees
196
Market Cap
351.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.48M | -25.20M | -36.17% |
| Dec 31, 2024 | 69.67M | -8.02M | -10.32% |
| Dec 31, 2023 | 77.70M | 35.20M | 82.83% |
| Dec 31, 2022 | 42.50M | 5.88M | 16.07% |
| Dec 31, 2021 | 36.61M | 2.32M | 6.76% |
| Dec 31, 2020 | 34.30M | 1.14M | 3.43% |
| Dec 31, 2019 | 33.16M | -42.96B | -99.92% |
| Dec 31, 2018 | 42.99B | 42.96B | 148,135.43% |
| Dec 31, 2017 | 29.00M | 9.47M | 48.48% |
| Dec 31, 2016 | 19.53M | 2.61M | 15.41% |
| Dec 31, 2015 | 16.92M | 4.34M | 34.49% |
| Dec 31, 2014 | 12.59M | 12.31M | 4,456.93% |
| Dec 31, 2013 | 276.17K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.38B |
| Fresenius SE & Co. KGaA | 23.28B |
| Siemens Healthineers AG | 23.17B |
| Merck KGaA | 21.14B |
| Medios AG | 2.16B |
| MEDICLIN Aktiengesellschaft | 819.84M |
| Evotec SE | 717.28M |
| M1 Kliniken AG | 364.30M |
Formycon AG News
- 14 days ago - Formycon AG Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Formycon AG Quarterly report: Q2 2026 - Filings
- 14 days ago - Formycon AG Earnings release: Q2 2026 - Filings
- 14 days ago - Formycon AG Slides: Q2 2026 - Filings
- 15 days ago - EQS-News: Formycon reports key operational achievements in the first half of 2026 and significantly improves financial results year-on-year - Wallstreet:Online
- 22 days ago - EQS-News: Formycon invites to conference call on 2026 half-year results and announces participation in international investor conferences - Wallstreet:Online
- 23 days ago - EQS-AFR: Formycon AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 6 weeks ago - EQS-News: Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars - Wallstreet:Online